SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ascendis Reports Five-Year Kidney Function Gains With TransCon PTH

Pooled Phase 2/3 data showed early, sustained eGFR improvements and lower urine calcium in adults with hypoparathyroidism treated with TransCon PTH for up to five years.

ASND

Related stories